Breaking News
July 17, 2018 - Advanced MRI technique predicts risk of disease progression in MS
July 17, 2018 - Health Tip: Microwave Safely – Drugs.com MedNews
July 17, 2018 - New target for treating heart failure identified
July 17, 2018 - Biodesign fellows simplify heart rhythm monitoring
July 17, 2018 - Study reveals new risk genes for allergic rhinitis
July 17, 2018 - Community college education can increase physician diversity and access to primary care
July 17, 2018 - Inflection Biosciences’ dual mechanism inhibitor shows promise as treatment for CLL
July 17, 2018 - Researchers uncover how cells invite corrupted proteins inside
July 17, 2018 - Studies show HORIBA’s new hematology analyzer improves POCT and care of oncology patients
July 17, 2018 - New website aims to make yoga safer for everyone
July 17, 2018 - Long-term survival worse for black survivors of in-hospital cardiac arrest
July 17, 2018 - Stanford data analyst’s childhood inspires his research: A Q&A
July 17, 2018 - Preventability of hospital readmissions changes over time, study reveals
July 17, 2018 - Nursing notes can help predict if ICU patients will survive
July 17, 2018 - Okayama University research could improve prognosis of diabetic kidney disease
July 17, 2018 - Homogenous BTK occupancy assay used in tirabrutinib clinical studies
July 17, 2018 - Study identifies new genes linked to heart function and development
July 17, 2018 - NeuroTrauma Sciences and Henry Ford join hands to advance exosome technology
July 17, 2018 - Improved methods to measure enterococci concentrations in recreational water
July 17, 2018 - White adolescent boys experiencing early puberty have high risk for substance use
July 17, 2018 - Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
July 17, 2018 - Roots of leukemia reveal possibility of predicting people at risk
July 17, 2018 - Summer med program embraces low-income students’ potential
July 17, 2018 - New research lays foundation to create standards for RNA sequencing
July 17, 2018 - CRISPR/Cas9 gene editing can cause greater genetic damage than previously thought
July 17, 2018 - Democrats rally against threats to the ACA to block Trump’s Supreme Court nominee
July 17, 2018 - Staggering prices slow insurers’ coverage of CAR-T cancer therapy
July 17, 2018 - How proteins involved in neurodegeneration enter cells
July 17, 2018 - New super-resolution ‘nanoscope’ provides insight into progression of Alzheimer’s disease
July 17, 2018 - FDA Advisory Committee Endorses the Effectiveness and Safety of Single-Dose Tafenoquine for the Radical Cure of P. vivax Malaria
July 17, 2018 - Uncovering the evolutionary history of IBD-associated colorectal cancer
July 17, 2018 - Is nutrition research dependable? Stanford’s John Ioannidis weighs in
July 17, 2018 - New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions
July 17, 2018 - Plant-based products fail to have positive impact on blood pressure during clinical studies
July 17, 2018 - Electronic system to speed up facial pain diagnosis may improve quality of life and save money
July 17, 2018 - Study delves into the role played by Protein Kinase C in synaptic plasticity
July 17, 2018 - Women Often Unaware of Their Hospital’s Religious Affiliation
July 17, 2018 - New AASM guideline recommends use of actigraphy for sleep disorders
July 17, 2018 - CRISPR editing reduces repetitive behavior in mice with a form of autism
July 17, 2018 - Scientists use magnets to detect cancer
July 17, 2018 - Microfluidic chip to detect sepsis proves successful in clinical study
July 17, 2018 - Research provides better understanding of mechanisms underlying memory storage
July 17, 2018 - A Multi-Modal Approach for the Early Detection of Breast Cancer
July 17, 2018 - Mailing colorectal cancer tests to patients increases screening rates, report researchers
July 17, 2018 - Scientists find possible sources of medicinal and antimicrobial drugs
July 17, 2018 - Molecules formed when the body metabolizes omega-3 fatty acids may inhibit cancer
July 17, 2018 - Efficient communication between hospitals improves patient safety and reduces mortality
July 17, 2018 - Study highlights potential of fetal gene therapy to prevent lethal neurodegenerative disease
July 17, 2018 - For Americans, in Science They Trust
July 17, 2018 - Combating HIV/AIDS | NIH MedlinePlus the Magazine
July 17, 2018 - Study shows minorities widely underrepresented in autism diagnoses
July 17, 2018 - Multigene testing replacing BRCA tests for breast cancer risk | News Center
July 17, 2018 - Pre-clinical pilot study shows promising results of ‘concussion pill’
July 17, 2018 - Researchers reduce size of tumors in mice by artificially activating the brain’s reward system
July 17, 2018 - New study documents symptoms of people before they acquire multiple sclerosis
July 17, 2018 - Researchers discover why CRISPR gene editing sometimes fails
July 17, 2018 - New finding may hold key to better understand the complexities of neurological disorders
July 17, 2018 - The Current issue of “The view from here” is concerned with Novel Targets.
July 17, 2018 - Fighting the Flu with a Universal Vaccine
July 17, 2018 - Key social reward circuit in the brain impaired in kids with autism | News Center
July 17, 2018 - Insight into causes, types and treatment of aphasia
July 16, 2018 - Quark Pharmaceuticals, Inc Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
July 16, 2018 - NSAIDs shown to have causal role in cardiovascular risk of patients with osteoarthritis
July 16, 2018 - PET scan tracer predicts success of cancer ‘vaccine’ | News Center
July 16, 2018 - Parents struggle with what to do when their child has headache, shows study
July 16, 2018 - Outrageous or overblown? HHS announces another round of ACA navigator funding cuts
July 16, 2018 - Weight loss surgery may impact individual’s risk of developing cancer, shows study
July 16, 2018 - Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
July 16, 2018 - Restoring epigenetic balance reinstates memory in flies with Alzheimer’s disease symptoms
July 16, 2018 - Magnetized wire could be used to detect cancer in people | News Center
July 16, 2018 - Non-surgical management found to be feasible option for penetrating kidney trauma
July 16, 2018 - California clinic screens asylum seekers for honesty
July 16, 2018 - FDA Approves Xtandi (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
July 16, 2018 - Can nanotechnology help treat Alzheimer’s?
July 16, 2018 - Researchers identify protein essential for making stem cells | News Center
July 16, 2018 - Severe childhood infections linked with lower school achievement in adolescence
July 16, 2018 - Radiologist discusses causes, treatments of varicose veins
July 16, 2018 - Researchers develop nanostructured surface to accelerate wound healing after dental implants
July 16, 2018 - New non-invasive procedure to reposition kidney stones could benefit astronauts
July 16, 2018 - Attending Surgeon Influences Genetic Testing in Breast Cancer
Facial Scarring Improved with Botulinum Toxin

Facial Scarring Improved with Botulinum Toxin

image_pdfDownload PDFimage_print

Action Points

  • Note that this small randomized trial suggested that botulinum toxin may be superior to placebo for reducing certain scar characteristics after a laceration closure.
  • Be aware that the primary outcome, score on the Vancouver Scar Scale, was not significantly different between the two groups, but this may be due to the small sample size for comparison.

Intradermal injection of botulinum toxin type A (Botox) immediately following wound closure improved the appearance of facial surgical scars compared with control scars in a small, randomized, double-blind trial from the People’s Republic of China.

At 6 months’ follow-up, the half of each facial scar treated with the injections following wound closure was narrower and flatter than the half left untreated, Li Hu, MD, PhD, and colleagues from the Shanghai Jiao Tong University School of Medicine Shanghai, reported in Plastic and Reconstructive Surgery.

The mean Vancouver Scar Scale score, used to characterize hypertrophic scars, was also lower for the half of the scar that was treated with the toxin, at 4.68 compared with 5.24 for the half that was not treated, although this difference was not statistically significant (P=0.146), the investigators added.

“Too many reports have focused on the treatment rather than the prevention of untoward surgical scars. However, early management of surgical scars is more likely to yield a better cosmetic appearance and require fewer treatments. This study demonstrates that early postsurgical botulinum toxin injections can produce better, narrower, and flatter facial surgical scars [than scars that remain untreated].”

For the study, 16 patients were randomized to receive botulinum toxin type A injections to half of their facial scar and the other half of the scar was treated with 0.9% normal saline.

“Immediately after skin closure, the encoded vial contents (0.2 mL containing 10 U for each 1-cm scar) were injected at a distance of 5 mm on either side of the wound,” the team wrote. The mean amount of botulinum toxin injected per scar was 33.7 U (range, 15 to 80 U). The mean age of the subjects was 12 (range, 6 to 49), while the mean length of the scar was 6.74 cm (range, 3 to 16 cm). The original diagnoses included congenital melanocytic nevi, port-wine stains, arteriovenous malformations, and disfiguring scars. Fourteen of the 16 patients completed the study.

In a subset analysis, the difference in the Vancouver Scar Scale height score at 6 months was significantly lower, at 0.47 for the treated part of the scar compared with 0.76 for the half that was not treated (P=0.009). At the same time point, the treated portion of the scar was also significantly narrower at 0.32, compared with 0.43 (P=0.001) for the untreated segment of the scar. The mean visual analogue scale (VAS) score was also higher at 5.76 for the treated part of the scar, compared with 4.97 for the control side — a difference between the two sides that was again significant (P=0.046).

In contrast, no significant differences were seen in the subdomains of pigmentation at 1.63 for the treated side versus 1.58 for the control side (P=0.391) or in vascularity, at 1.24 for the treated side versus 1.32 for the control side (P=0.263). No adverse events were noted. Tension at the edges of a wound significantly contributes to unsightly scars, the researchers explained.

“Temporary muscular paralysis induced by botulinum toxin type A could decrease movement and stress around a healing wound. This relief of tension may help prevent facial scar widening, hypertrophy, and hyperpigmentation.”

The authors also noted that botulinum toxin may have a direct inhibitory effect on fibroblasts and transforming growth factor-β1 expression, both key to the development of hypertrophic scars. A previously published study similarly found that early injections of the same botulinum toxin improved the appearance of facial scars — again by inducing temporary muscle paralysis and decreasing tension on wound edges.

Asked for her opinion, Tina Alster, MD, director of the Washington Institute of Dermatologic Laser Surgery in Washington, D.C., who was not involved with the study, pointed out that one of the limitations was the small sample size. She also noted that in general, scars on the face and neck tend to heal fairly well, as they are not under a lot of tension, which can contribute to unsightly scars.

However, she said she agreed in principle that starting early to try and minimize scars is a good idea: “I do a lot of laser scar revision and even using lasers to reverse red or hypertrophic keloid scars, we found that the earlier you start using the laser, the less severe the scar, and the earlier the scar looks better.”

In addition, Alster said, for many practitioners, incorporating the use of botulinum toxin into the practice of scar management is likely to be more readily available than the use of lasers, although in her own practice, she has found it actually to be less expensive and even less invasive to use a laser for scar revision than to inject botulinum toxin around a wound.

“I think it’s an important study if only because it asks the question, will the use of Botox or any of the other neuromodulators reduce scar formation by directly reducing the mechanical forces across a wound bed, and that answer is likely yes.”

“So in general this is a ‘thumbs up’ study, but with the caveat that larger studies of more significant scars are still warranted.”

The study authors, as well as Alster, reported having no financial conflicts of interest.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-03-13T12:00:00-0400

Tagged with:

About author

Related Articles